Clinical Trial Update: Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211)

View source ↗

Summary

Update on the ANTG-ASC-211 follow-up trial using autologous adipose-derived stem cells for complex perianal fistula; the study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perianal Fistula

Drugs mentioned

• ANTG-ASC (autologous adipose-derived stem cells)

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Perianal Fistula, Primary; Complex | Status: TERMINATED